As of April 16, 2025, Dermapharm (DMP.F) has a market cap of $2.34 billion USD. According to our data, Dermapharm is ranked No.3744 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.34 B |
-0.83%
|
Dec 30, 2024 | $2.36 B |
-6.24%
|
Dec 29, 2023 | $2.52 B |
14.89%
|
Dec 30, 2022 | $2.19 B |
-55.71%
|
Dec 30, 2021 | $4.94 B |
57.47%
|
Dec 30, 2020 | $3.14 B |
45.47%
|
Dec 30, 2019 | $2.16 B |
83.42%
|
Dec 28, 2018 | $1.18 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
Market Cap | = | DMP.F Stock Price | * | DMP.F Shares Outstanding |
= | $42.39 | * | 53.84 M | |
= | $2.34 B |